{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:42:39Z","timestamp":1790185359790,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870258"],"award-info":[{"award-number":["81870258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82150006"],"award-info":[{"award-number":["82150006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.maturitas.2023.04.009","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T07:37:16Z","timestamp":1681976236000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Intensive blood pressure control for patients aged over 60: A meta-analysis of the SPRINT, STEP, and ACCORD BP randomized controlled trials"],"prefix":"10.1016","volume":"172","author":[{"given":"Xiaoting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.maturitas.2023.04.009_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.maturitas.2023.04.009_bb0010","series-title":"Effect of Antihypertensive Drug Treatment on Long-term Blood Pressure Reduction: An Individual Patient-level Data Meta-analysis of 352,744 Participants From 51 Large-scale Randomised Clinical Trials","year":"2021"},{"issue":"5","key":"10.1016\/j.maturitas.2023.04.009_bb0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin. Res. Cardiol."},{"issue":"9349","key":"10.1016\/j.maturitas.2023.04.009_bb0020","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2023.04.009_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.phrs.2017.10.003","article-title":"Treatment of hypertension: the ESH\/ESC guidelines recommendations","volume":"128","author":"Cuspidi","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.maturitas.2023.04.009_bb0030","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacc.2014.06.014","article-title":"2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations","volume":"64","author":"Krakoff","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"29","key":"10.1016\/j.maturitas.2023.04.009_bb0035","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.maturitas.2023.04.009_bb0040","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.maturitas.2023.04.009_bb0045","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the Management of Arterial Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.maturitas.2023.04.009_bb0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.maturitas.2023.04.009_bb0055","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.maturitas.2023.04.009_bb0060","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2337\/dc17-1366","article-title":"Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP","volume":"40","author":"Buckley","year":"2017","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.maturitas.2023.04.009_bb0065","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.maturitas.2023.04.009_bb0070","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/HYPERTENSIONAHA.117.10479","article-title":"Blood pressure measurement in SPRINT (systolic blood pressure intervention trial)","volume":"71","author":"Johnson","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.maturitas.2023.04.009_bb0075","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/HYPERTENSIONAHA.116.07257","article-title":"Unattended blood pressure measurements in the systolic blood pressure intervention trial: implications for entry and achieved blood pressure values compared with other trials","volume":"67","author":"Kjeldsen","year":"2016","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.maturitas.2023.04.009_bb0080","first-page":"444","article-title":"Benefits and potential risks of intensive goals in the treatment of arterial hypertension - systematic review and meta-analysis of clinical trials","volume":"90","author":"Garcia-Zamora","year":"2020","journal-title":"Arch. Cardiol. Mex."},{"issue":"10022","key":"10.1016\/j.maturitas.2023.04.009_bb0085","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.maturitas.2023.04.009_bb0090","article-title":"Blood pressure targets for the treatment of people with hypertension and cardiovascular disease","volume":"9","author":"Saiz","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"9943","key":"10.1016\/j.maturitas.2023.04.009_bb0095","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.maturitas.2023.04.009_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med."},{"issue":"12","key":"10.1016\/j.maturitas.2023.04.009_bb0105","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/HJH.0000000000000378","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"J. Hypertens."},{"issue":"10017","key":"10.1016\/j.maturitas.2023.04.009_bb0110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.maturitas.2023.04.009_bb0115","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.clinthera.2016.08.007","article-title":"More versus less blood pressure lowering: an update","volume":"38","author":"Atkins","year":"2016","journal-title":"Clin. Ther."},{"issue":"14","key":"10.1016\/j.maturitas.2023.04.009_bb0120","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/heartjnl-2019-314882","article-title":"Blood pressure management in the elderly: the need for more randomised evidence","volume":"105","author":"Pinho-Gomes","year":"2019","journal-title":"Heart"},{"issue":"27","key":"10.1016\/j.maturitas.2023.04.009_bb0125","first-page":"2590","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Deng","year":"2021","journal-title":"Reply, N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.maturitas.2023.04.009_bb0130","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.maturitas.2023.04.009_bb0135","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control","volume":"384","author":"Lewis","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.maturitas.2023.04.009_bb0140","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.maturitas.2023.04.009_bb0145","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.maturitas.2023.04.009_bb0150","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/sim.4780081211","article-title":"Efficiency of the logistic regression and cox proportional hazards models in longitudinal studies","volume":"8","author":"Annesi","year":"1989","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2023.04.009_bb0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"issue":"7414","key":"10.1016\/j.maturitas.2023.04.009_bb0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7626","key":"10.1016\/j.maturitas.2023.04.009_bb0165","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"Ioannidis","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2023.04.009_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2023.04.009_bb0175","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"8692","key":"10.1016\/j.maturitas.2023.04.009_bb0180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias","volume":"335","author":"MacMahon","year":"1990","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.maturitas.2023.04.009_bb0185","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/ajh\/hpu053","article-title":"Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey","volume":"27","author":"Wang","year":"2014","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.maturitas.2023.04.009_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.maturitas.2023.04.009_bb0195","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamainternmed.2017.4377","article-title":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis","volume":"177","author":"Malhotra","year":"2017","journal-title":"JAMA Intern. Med."},{"issue":"10305","key":"10.1016\/j.maturitas.2023.04.009_bb0200","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.maturitas.2023.04.009_bb0205","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"9891","key":"10.1016\/j.maturitas.2023.04.009_bb0210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"issue":"9590","key":"10.1016\/j.maturitas.2023.04.009_bb0215","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.maturitas.2023.04.009_bb0220","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","article-title":"Follow-up of blood-pressure lowering and glucose control in type 2 diabetes","volume":"371","author":"Zoungas","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.maturitas.2023.04.009_bb0225","first-page":"981","article-title":"The STEP study: at what levels to reduce blood pressure in hypertensive patients?","volume":"22","author":"Verdecchia","year":"2021","journal-title":"G. Ital. Cardiol."},{"issue":"1","key":"10.1016\/j.maturitas.2023.04.009_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14779072.2022.2034500","article-title":"Improving outcomes for older hypertensive patients: is more intensive treatment better?","volume":"20","author":"Deng","year":"2022","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"11","key":"10.1016\/j.maturitas.2023.04.009_bb0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41569-021-00626-0","article-title":"Intensive blood pressure control benefits older patients","volume":"18","author":"Fern\u00e1ndez-Ruiz","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"14","key":"10.1016\/j.maturitas.2023.04.009_bb0240","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMe2112992","article-title":"Moving the goalposts for blood pressure - time to act","volume":"385","author":"Nelson","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.maturitas.2023.04.009_bb0245","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.recesp.2018.01.015","article-title":"New targets in arterial hypertension, are they justified?","volume":"71","author":"Barrios","year":"2018","journal-title":"Rev. Espanol. Cardiol."},{"issue":"6","key":"10.1016\/j.maturitas.2023.04.009_bb0250","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.recesp.2019.01.006","article-title":"Is the evidence provided by the SPRINT trial solid enough to support a systolic blood pressure threshold of 120 mmHg?","volume":"72","author":"Garc\u00eda-Zamora","year":"2019","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"10.1016\/j.maturitas.2023.04.009_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3863","article-title":"Problems of stopping trials early","volume":"344","author":"Guyatt","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.maturitas.2023.04.009_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41440-021-00764-5","article-title":"STEP to estimate cardiovascular events by home blood pressure in the era of digital hypertension","volume":"45","author":"Kario","year":"2022","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.maturitas.2023.04.009_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41440-021-00765-4","article-title":"Utility of the \"strategy of blood pressure intervention in elderly hypertensive patients\" for home blood pressure management in a real-world setting","volume":"45","author":"Ohkubo","year":"2022","journal-title":"Hypertens. Res."},{"issue":"12","key":"10.1016\/j.maturitas.2023.04.009_bb0270","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/HJH.0000000000000379","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels\u2013overview and meta-analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.maturitas.2023.04.009_bb0275","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41371-019-0221-z","article-title":"Effect of intensive lowering of systolic blood pressure treatment on heart failure events: a meta-analysis of randomized controlled studies","volume":"33","author":"Zhang","year":"2019","journal-title":"J. Hum. Hypertens."},{"issue":"7","key":"10.1016\/j.maturitas.2023.04.009_bb0280","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2213-8587(18)30099-8","article-title":"Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials","volume":"6","author":"Beddhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"10.1016\/j.maturitas.2023.04.009_bb0285","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028698","volume":"9","author":"Rahimi","year":"2019","journal-title":"BMJ Open"},{"issue":"10285","key":"10.1016\/j.maturitas.2023.04.009_bb0290","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512223000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512223000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:10:02Z","timestamp":1777569002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512223000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":58,"alternative-id":["S0378512223000713"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2023.04.009","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive blood pressure control for patients aged over 60: A meta-analysis of the SPRINT, STEP, and ACCORD BP randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2023.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}